The inspection closed with seven observations. There were no data integrity related observations. The company will closely work with the USFDA to address the observations expeditiously.

The inspection closed with seven observations. Zydus Life said there were no data integrity-related observations and that it ...

USFDA concludes inspection at Zydus Biologics'' Ahmedabad injectable plant with 7 observations. No data integrity issues noted.

Today, Gubra releases its results for the first quarter of 2026, building on a record year in 2025. In the quarter, we advanced our Biotech business, not least shown by strong results and progress for ...

Zydus Lifesciences rose 2.23% to Rs 932.15 after the company said the US Food and Drug Administration completed a GMP surveillance inspection at its biologics injectable manufacturing facility in ...

It has been known for years by insiders as the “hidden gem” of North Carolina’s life sciences ecosystem. And now, after four ...

The Federico II University of Naples is preparing to celebrate Mother’s Day one day early with a special event dedicated to ...

Madrigal Pharmaceuticals' hunger for fresh metabolic dysfunction-associated steatohepatitis (MASH) drugs shows no sign of ...

Authorities identify nine victims of the Kerala fireworks unit blast, sparking discussions on a fireworks-free Thrissur Pooram.

April 21 (Reuters) - Life sciences firm Danaher topped first-quarter profit expectations on Tuesday, fueled by strong demand for its bioprocessing tools used in drug manufacturing, lifting shares 2% ...

Thermo Fisher Scientific is shedding its microbiology business to private equity firm Astorg nearly a year after initial ...

Judd O’Connor - Executive Vice President of Seed Business Unit Robert King - Executive Vice President of Crop Protection Business Unit Good morning, and welcome to Corteva's First Quarter 2026 ...